Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea N Edginton

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Paediatric Anaesthesia|December 7, 2010
Knowledge-driven approaches for the guidance of first-in-children dosingAndrea N Edginton
Expert Opinion on Drug Metabolism & Toxicology|July 19, 2011
Have physiologically-based pharmacokinetic models delivered?Andrea N Edginton, Ghanashyam Joshi
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 19, 2012
Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar developmentElliot Offman, Andrea N Edginton
Clinical Pharmacokinetics|October 9, 2008
Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosisAndrea N Edginton, Stefan Willmann
European Journal of Drug Metabolism and Pharmacokinetics|February 4, 2016
Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human InvestigationElliot Offman, Andrea N Edginton
Environmental Science & Technology|November 22, 2005
Toxicokinetics of 14C-atrazine and its metabolites in stage-66 Xenopus laevisAndrea N Edginton, Claude Rouleau
Environmental Health Perspectives|May 15, 2009
Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic modelAndrea N Edginton, Len Ritter
Journal of Pharmacokinetics and Pharmacodynamics|February 5, 2015
A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptideElliot Offman, Andrea N Edginton
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 16, 2016
Examining Small Intestinal Transit Time as a Function of Age: Is There Evidence to Support Age-Dependent Differences among Children?Anil R Maharaj, Andrea N Edginton
Journal of Toxicology and Environmental Health. Part A|August 14, 2019
Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compoundsYejin Esther Yun, Andrea N Edginton
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Paediatric Anaesthesia|December 7, 2010
Knowledge-driven approaches for the guidance of first-in-children dosingAndrea N Edginton
Expert Opinion on Drug Metabolism & Toxicology|July 19, 2011
Have physiologically-based pharmacokinetic models delivered?Andrea N Edginton, Ghanashyam Joshi
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 19, 2012
Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar developmentElliot Offman, Andrea N Edginton
Clinical Pharmacokinetics|October 9, 2008
Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosisAndrea N Edginton, Stefan Willmann
European Journal of Drug Metabolism and Pharmacokinetics|February 4, 2016
Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human InvestigationElliot Offman, Andrea N Edginton
Environmental Science & Technology|November 22, 2005
Toxicokinetics of 14C-atrazine and its metabolites in stage-66 Xenopus laevisAndrea N Edginton, Claude Rouleau
Environmental Health Perspectives|May 15, 2009
Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic modelAndrea N Edginton, Len Ritter
Journal of Pharmacokinetics and Pharmacodynamics|February 5, 2015
A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptideElliot Offman, Andrea N Edginton
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 16, 2016
Examining Small Intestinal Transit Time as a Function of Age: Is There Evidence to Support Age-Dependent Differences among Children?Anil R Maharaj, Andrea N Edginton
Journal of Toxicology and Environmental Health. Part A|August 14, 2019
Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compoundsYejin Esther Yun, Andrea N Edginton
Pageof 10